Background: The Canadian Psychiatric Association and the Canadian Network for Mood and Anxiety Treatments partnered to produce clinical guidelines for psychiatrists for the treatment of depressive disorders.
Methods: A standard guidelines development process was followed. Relevant literature was identified using a computerized Medline search supplemented by review of bibliographies. Operational criteria were used to rate the quality of scientific evidence, and the line of treatment recommendations included consensus clinical opinion. This section on "Definitions, Prevalence, and Health Burden” was 1 of 7 articles drafted and reviewed by clinicians. Revised drafts underwent national and international expert peer review.
Results: The 1-year prevalence rate of major depressive disorder (MDD) in Canada is 3.2% to 4.6%, similar to the rates in other countries. MDD frequently runs a chronic or recurrent course and carries high risks for mortality and morbidity. The significant economic costs and disability associated with depressive illness are reduced by effective treatment.
Conclusions: MDD is a prevalent medical condition that results in a significant health burden in the world. Vigorous efforts to improve diagnosis, treatment, and prevention are indicated to reduce the societal and personal costs of depressive disorders.
References
1.
WeissmanMMBlandRCCaninoGJFaravelliCGreenwaldSHwuHG, and others. Cross-nalional epidemiology of major depression and bipolar disorder JAMA1996;276:293-9.
2.
GrofP.The age of misery: affective disorders on the rise. Can J Psychiatry1997;42:361-2.
3.
DavidsonJRMeltzer-BrodySE.The underrecognition and undertreatment of depression: what is the breadth and depth of the problem?J Clin Psychiatry1999;60 (7):4-9
4.
MurrayCJLopezAD.Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet1997;349:1498-1504.
5.
JonesRYatesWRWilliamsSZhouMHardmanL.Outcome for adjustment disorder with depressed mood: comparison with other mood disorders. J Affect Disord1999;55:55-61.
6.
PiniSPerkonnigATansellaMWittchenHUPrevalencePsich D.outcome12-monthof threshold and subthreshold mental disorders in primary care. J Affect Disord1999;56:37-48.
7.
SpanerDBlandRCNewmanSC.Epidemiology of psychiatric disorders in Edmonton. Major depressive disorder. Acta Psychiatr Scand Suppl1994;376:7-15.
8.
WeissmanMMBruceMLLeafPJFlorioLPHolzerG.Affective disorders. In: Robins LN, Regier DA, editors. Psychiatric disorders in America. New York: Free Press; 1991. p 53-80.
9.
BlandRCNewmanSCAgeOrn H.ofremissionpsychiatric disorders. Can J Psychiatry1997;42:722-9.
10.
Mueller Tl, Leon AC, Keller MB. Solomon DA, Endicott J, Coryell W, and others. Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. Am J Psychiatry1999;156:1000-6.
11.
LeeASMurrayRM.The long-term outcome of Maudsley depressives. Br J Psychiatry1988;153:741-51.
12.
KellerMBShapiroRWLavoriPWWolfeN.Recovery in major depressive disorder: analysis with the life table and regression models. Arch Gen Psychiatry1982;39:905-10.
13.
ThornicroftGSartoriusN.The course and outcome of depression in different cultures: 10-year follow-up of the WHO collaborative study on the assessment of depressive disorders. Psychol Med1993;23:1023-32.
14.
JuddLLAkiskalHSMaserJDZellerPJEndicottJCoryellW, and others. A prospective 12-year study of subsyndromal and syndromal depressive symptoms in unipolar major depressive disorders. Arch Gei. Psychiatry1998;55:694-700.
15.
KellerMBLavoriPWMuellerTIEndicottJCoryellW, and others. Time to recovery, chronicity, and levels of psychopathology in major depression. A 5-year prospective follow-up of 431 subjects. Arch Gen Psychiatry1992;49:809-16.
16.
KellerMB. Dysthymia in clinical practice: course, outcome and impact on the community. Acta Psychiatr Scand Suppl1994;383:24-34.
17.
KeitnerGIRyanCEMillerIWRecoveryNorman WH.and major depression: factors associated with twelve-month outcome. Am J Psychiatry1992;149:93-9.
18.
KellerMB. Overview of depression: chronicity, recurrence, morbidity and the need for maintenance treatment. R I Med1993;76:381-6.
19.
KeitnerGIRyanCEMillerIWKohnRBishopDSEpsteinNB.Role of the family in recovery and major depression. Am J Psychiatry1995;152:1002-8.
20.
CoryellWEndicottJKellerM.Outcome of patients with chronic affective disorder: a five-year follow-up. Am J Psychiatry1990;147:1627-33.
21.
KeitnerGIRyanCEMillerIWZlotnickC.Psychosocial factors and the longterm course of major depression. J Affect Disord1997;44:57-67.
22.
BallengerJC.Clinical guidelines for establishing remission in patients with depression and anxiety. J Clin Psychiatiy1999;60 (22):29-34
23.
JuddLLAkiskalHSMaserJDZellerPJEndicottJCoryellW, and others. Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. J Affect Disord1998;50:97-108.
24.
JohnsonJHorwathEWeissmanMM.The validity of major depression with psychotic features based on a community study. Arch Gen Psychiatry1991;48:1075-81.
25.
Cory ell W, Leon A, Winokur G, Endicott J, Keller M, Akiskal H, and others. Importance of psychotic features to long-term course in major depressive disorder. Am J Psychiatry1996;153:483-9.
26.
KendlerKS.The diagnostic validity of melancholic major depression in a population-based sample of female twins. Arch Gen Psychiatry1997;54:299-304.
27.
StewartJWMcGrathPJRabkinJGQuitkinFM.Atypical depression. A valid clinical entity? Psychiatr Clin North Am1993;16:479-95.
28.
LamRWStewartJN.The validity of atypical depression in DSM-IV. Compr Psychiatry1996;37:375-83.
29.
FavaMRankinMAWrightECAlpertJENierenbergAAPavaJRosenbaumJF.Anxiety disorders in major depression. Compr Psychiatry2000;41:97-102.
30.
Roy-BymePPStangPWittchenHUUstunBWaltersEEKesslerRC. Lifetime panic-depression comorbidity in the national comorbidity survey. Association with symptoms, impairment, course and help-seeking, Br J Psychiatry 2000;176:229-35.
31.
ParikhSVLesageADKennedySHGoeringPN.Depression in Ontario: undertreatment and factors related to antidepressant use. J Affect Disord1999;52:67-76.
32.
HirschfeldRM.Personality disorders and depression: comorbidity. Depress Anxiety1999;10:142-6.
33.
SkodolAEStoutRLMcGlashanTHGriloCMGundersonJGSheaMT, and others. Co-occurrence of mood and personality disorders: a report from the collaborative longitudinal personality disorders study (CLPS). Depress Anxiety1999;10:175-82.
34.
KellerMBGelenbergAJHirschfeldRMRushAJThaseMEKocsisJH, and others. The treatment of chronic depression, part 2: a double-blind, randomized trial of sertraline and imipramine. J Clin Psychiatry1998;59:598-607.
35.
AlnaesRPersonalityTorgersen S.disorderspersonalitypredict development and relapses of major depression. Acta Psychiatr Scand1997;95:336-42.
36.
PattenSB.Long-term medical conditions and major depression in the Canadian population. Can J Psychiatry1999;44:151-7.
37.
Frasure-SmithNLesperanceFTalajicM. Depression following myocardial infarction. Impact on 6-month survival. JAMA1993;270:1819-25.
38.
MurphyJMLairdNMMonsonRRSobolAMLeightonAH.A 40-year perspective on the prevalence of depression: the Stirling County study. Arch Gen Psychiatry2000;57:209-15.
39.
BlandRCNewmanSCOmH.Period prevalence of psychiatric disorders in Edmonton. Acta Psychiatr Scand Suppl1988;338:33-42.
40.
ParikhSVWasylenkiDGoeringPWongJ. Mood disorders: rural urban differences in prevalence, health care utilization, and disability in Ontario. J Affect Disord1996;38:57-65.
41.
LegareG. Direction generale de la sante publique du Bas-St-Laurent. La prevalence des troubles mentaux dans le Bas-St-Laurent. Fait saillant, Enquete Sante Mentale 1995.
42.
Cross-National Collaborative Group. The changing rate of major depression. Cross-national comparisons. JAMA1992;268:3098-105.
43.
WeissmanMMBlandRJoycePRNewmanSWellsJEWittchenHU.Sex differences in rates of depression: cross-national perspectives. J Affect Disord1993;29:77-84.
44.
BlandRCOmHNewmanSC.Lifetime prevalence of psychiatric disorders in Edmonton. Acta Psychiatr Scand Suppl1988;338:24-32.
45.
PattenSB.Incidence of major depression in Canada. CMAJ2000;163:714-5.
46.
LinESociodemographicParikh SV., clinical, and attitudinal characteristics of the untreated depressed in Ontario. J Affect Disord1999;53:153-62.
47.
JablenskyASartoriusNGulbinatWEmbergG. Characteristics of depressive patients contacting psychiatric services in four cultures. A report from the WHO collaborative study on the assessment of depressive disorders. Acta Psychiatr Scand1981;63:367-83.
48.
WellsKBStromRSherboumeCDMeredithLS. Caring for depression: a RAND study. Cambridge: Harvard University Press; 1996.
49.
OrmelJVonKorffMOldehinkelAJSimonGTiemensBGUstunTB.Onset of disability in depressed and non-depressed primary care patients. Psychol Med1999;29:847-53.
50.
KesslerRCBarberCBimbaumHGFrankRGGreenbergPERoseRM, and others. Depression in the workplace: effects on short-term disability. Health Aff (Millwood) 1999;18:163-71.
51.
BroadheadWEBlazerDGGeorgeLKDepressionTse CK.daysdisabilitylostdaysfrom work in a prospective epidemiologic survey. JAMA1990;264:2524-8.
52.
DenihanABruceICoakleyDLawlorBA.Psychiatric morbidity in cohabitants of community-dwelling elderly depressives. Int J Geriatr Psychiatry1998;13:691-4.
53.
GoodmanSHGotlibIH.Risk for psychopathology in the children of depressed mothers: a developmental model for understanding mechanisms of transmission. Psychol Rev1999;106:458-90.
54.
GlozierN.Workplace effects of the stigmatization of depression. J Occup Environ Med1998;40:793-800.
55.
BerndtERFinkelsteinSNGreenbergPERHHow landKeithARushAJ, and others. Workplace performance effects from chronic depression and its treatment. J Health Econ 1998;17:511 35.
56.
JohnsonJWeissmanMMKlermanGL.Sen ice utilization and social morbidity associated with depressive symptoms in the community. JAMA 1992;267:1478 83.
57.
OlfsonMKlermanGL.Depressive symptoms and mental health service utilization in a community sample. Soc Psychiatry Psychiatr Epidemiol1992;27:161-7.
58.
Von KorffMOrmelJKatonWDisabilityLin EH.amongdepression high utilizers of health care. A longitudinal analysis. Arch Gen Psychiatry1992;49:91-100.
59.
KatzclnickDJSimonCEPearsonSDManningWGllelstadCPHenkHJ, and others. Randomized trial of a depression management program in high utilizers of medical care. Arch Fam Med2000;9:345-51.
60.
NewmanSCBlandRC.Suicide risk varies by subtype of affective disorder. Acta Psychiatr Scand1991;83:420-6.
61.
BostwiekJMPankratzVS. Affective disorders and suicide risk: A reexamination. Am J Psychiatry 2000;157:1925 32.
62.
LeenaarsAASuicideLester D.rateshomicide in Canada and the United States. Suicide Life Threat Behav 1994;24:184 91.
63.
SakinofskyILeenaarsAA.Suicide in Canada with special reference to the difference between Canada and the United States. Suicide Life Threat Behav I997;27:112-26.
64.
MaoYHasselbackPDaviesJWNicholRWigleDT.Suicide in Canada: an epidemiological assessment. Can J Public Health1990;81:324-8.
65.
WulsinLRVaillantGEWellsVE.A systematic review of the mortality of depression. Psychosom Med1999;61:6-17.
66.
BarefootJCHelmsMJMarkDBBlumenthalJACaliffRMHaneyTL, and others. Depression and long-term mortality risk in patients with coronary artery disease. Am J Cardiol1996;78:613-7.
67.
LesperanceFFrasure-SmithN.Depression in patients with cardiac disease: a practical review. J Psychosom Res2000;48:379-91.
68.
CarneyRMFreedlandKEVeithRCJaffeAS. Can treating depression reduce mortality after an acute myocardial infarction? Psychosom Med 1999;61:666-75
69.
MurrayCJGlobal mortalityLopez AD., disability, and the contribution of risk factors: global burden of disease study. Lancet1997;349:1436-42.
70.
GreenbergPE. Stiglin LE, Finkelstein SN, Berndt ER. The economic burden of depression in 1990. J Clin Psychiatry1993;54:405-18.
71.
GnamW. The economic costs of depressive disorders in Ontario, 1990 [MSc thesis]. Toronto, (ON): University of Toronto; 1997.
72.
KeitnerGIMillerIWfunctioningFamilyand major depression: an ovenview. Am J Psychiatry1990;147:1128-37.
73.
SimonGEVonKorffMBarlowW.Health care costs of primary care patients with recognized depression. Arch Gen Psychiatry1995;52:850-6.
74.
VerboskyLAFrancoKNZrullJP.The relationship between depression and length of stay in the general hospital patient. J Clin Psychiatry 1993;54:177-81
75.
ContiDJBurtonWN.The economic impact of depression in a workplace. J Occup Med1994;36:983-8.
76.
ContiDJBurtonWN.The cost of depression in the workplace. Behav Health Tomorrow1995;4:25-7.
77.
CoulehanJLSchulbergHCBlockMRMadoniaMJTreating depressed primary care patients improves their physicalRodriguez E., mental, and social functioning. Arch Intern Med 1997;157:11 13-20.
78.
SimonGERevickiDHeiligensteinJGrothausLVonKorffMKatonWJ, and others. Recovery from depression, work productivity, and health care costs among primary care patients. Gen Hosp Psychiatry2000;22:153-62.
79.
SturmRWellsKB.How can care for depression become more cost-effective?JAMA1995;273:51-8.
80.
KamletMSPaulNGreenhouseJKupferDFrankEWadeM.Cost utility analysis of maintenance treatment for recurrent depression. Control Clin Trials1995;16:17-40.
81.
LaveJRFrankRGSchulbergHCKamletMS.Cost-effectiv eness of treatments for major depression in primary care practice. Arch Gen Psychiatry1998;55:645-51.
82.
JonssonBBebbingtonPE. What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment. Br J Psychiatry1994;164:665-73.
83.
ZhangMRostKMFortneyJC.Earnings changes for depressed individuals treated by mental health specialists. Am J Psychiatry 1999;156:108-14
84.
ParikhSVLinELesageAD.Mental health treatment in Ontario: selected comparisons between the primary care and specialty sectors. Can J Psychiatry1997;42:929-34.
85.
KatesNCravenM. Shared mental health care. Canadian Psychiatric Association and College of Family Physicians of Canada Joint Working Group. Can Fam Physician1999;45:2143-60.
86.
KatonWMVon KorffLinESimonGWalkerEUnutzerJ, and others. Stepped collaborative care for primary care patients with persistent symptoms of depression: a randomized trial. Arch Gen Psychiatry I999;56:1109-15.
